GLP-1 medications aren't appropriate for everyone
Raising $18M in 24, it added kids version Cubs and Ntrops, a nootropic mushroom gummy for cognitive support with more SKUs expected this summer
Semaglutide (Ozempic and Wegovy) Semaglutide is the most widely used GLP-1 receptor agonist for weight loss
This is all part of giving customers more ways to start and help sustain their health journey based on their unique history, preferences, needs, and goals
Its also important to understand their criteria for appropriate use, including clinical criteria beyond just BMI, and the percentage of eligible patients who get approved for a GLP-1 prescription
This dual benefit makes them an important option for tackling multiple health issues